Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McGill University
$105,000.00
Genome-wide discovery of the causative mutations in hereditary cancers using next-generation RNA and exomic sequencing of human tumour samples.
FY 2010-11
Summary
The completion of the Human Genome Project was hailed as a major milestone in science. This 13-year project required hundreds of scientists and billions of dollars. Now, with the advent of next-generation sequencing (NGS), we can achieve the same result in under a week, for a few thousand dollars and requiring minimal staff. Moreover, NGS offers a much higher degree of sequencing detail and accuracy than previously achievable. Indeed, NGS has become an integral part of cancer genetics since it can detect any genetic abnormalities which may cause or contribute to cancer.
This project proposes the use of two complimentary applications of NGS to identify mutations which cause rare, familial types of cancer. We have a set of patient samples taken from families that have been affected by cancer for several generations. These families do not have the mutations which typically cause the cancer and as such this project provides a unique opportunity to find new cancer-causing genes.
NGS generates a vast amount of data to be mined and analyzed. This bioinformatics project involves writing computer software to identify the anomalies between the patients' tumour samples and healthy samples. The project will benefit greatly from methodologies that have been created and successfully implemented by the applicant over the past year using similar data.
Identification of new causative mutations will provide these families with the exact genetic cause of their increased cancer risk. This information can be used to predict future risk in undiagnosed individuals and can now even be used to prevent future generations from inheriting this mutation. With preimplantation genetic diagnosis and in-vitro fertilization, parents can ensure their child will not inherit the causative mutations before the embryo is even placed in the womb. Indeed, if any of the causative mutations are found to be common in cancer patients, these options will be available to a larger subset of patients.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
229572
Name
Lalonde Emilie R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Genome-wide discovery of the causative mutations in hereditary cancers using next-generation RNA and exomic sequencing of human tumour samples.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Genetics Of Cancer; Genome Alterations; Genomics/Transcriptomics; Hereditary Cancers; Next-Generation Sequencing; Transcript Alteration
Abstract
The completion of the Human Genome Project was hailed as a major milestone in science. This 13-year project required hundreds of scientists and billions of dollars. Now, with the advent of next-generation sequencing (NGS), we can achieve the same result in under a week, for a few thousand dollars and requiring minimal staff. Moreover, NGS offers a much higher degree of sequencing detail and accuracy than previously achievable. Indeed, NGS has become an integral part of cancer genetics since it can detect any genetic abnormalities which may cause or contribute to cancer.
This project proposes the use of two complimentary applications of NGS to identify mutations which cause rare, familial types of cancer. We have a set of patient samples taken from families that have been affected by cancer for several generations. These families do not have the mutations which typically cause the cancer and as such this project provides a unique opportunity to find new cancer-causing genes.
NGS generates a vast amount of data to be mined and analyzed. This bioinformatics project involves writing computer software to identify the anomalies between the patients' tumour samples and healthy samples. The project will benefit greatly from methodologies that have been created and successfully implemented by the applicant over the past year using similar data.
Identification of new causative mutations will provide these families with the exact genetic cause of their increased cancer risk. This information can be used to predict future risk in undiagnosed individuals and can now even be used to prevent future generations from inheriting this mutation. With preimplantation genetic diagnosis and in-vitro fertilization, parents can ensure their child will not inherit the causative mutations before the embryo is even placed in the womb. Indeed, if any of the causative mutations are found to be common in cancer patients, these options will be available to a larger subset of patients.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lalonde, Emilie R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~